Apollo Hospitals Enterprise APOLLOHOSP
Hospital group whose Apollo HealthCo arm runs India's largest pharmacy chain (7,000+ stores), Apollo 24/7 and, via Keimed, wholesale pharma distribution
Mapped in 2 themes: Nifty 50 and Pharmaceuticals.
Where Apollo Hospitals Enterprise sits in the supply chain
Apollo Hospitals Enterprise appears in 1 supply-chain layer in one theme, Pharmaceuticals.
Pharmaceuticals › Distribution & pharmacy retail
OperatorOther companies in this layer
Index membership
Apollo Hospitals Enterprise is in the Nifty 50 (NSE industry: Healthcare).
Revenue and profit
| ₹ Cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 19,059 | 21,794 | 25,228 |
| Net profit | 935 | 1,505 | 2,003 |
Latest-year revenue ₹25,228 Cr (FY26, company-wide). Wider screens show FY22 onwards.
Strengths
- Largest organised pharmacy network and wholesale arm (Keimed) give real scale in drug distribution
- Pharmacy and digital business is being demerged into Apollo Healthtech for a separate listing (targeted Q4 FY27)
Risks
- Pharmacy is a minority of value inside a hospital-led group until the demerger completes
- Apollo 24/7 digital losses and demerger execution risk
Common questions
What does Apollo Hospitals Enterprise do?
Hospital group whose Apollo HealthCo arm runs India's largest pharmacy chain (7,000+ stores), Apollo 24/7 and, via Keimed, wholesale pharma distribution.
Where does Apollo Hospitals Enterprise sit in the supply chain?
Apollo Hospitals Enterprise (NSE: APOLLOHOSP) is mapped in 1 supply-chain layer: Distribution & pharmacy retail (Pharmaceuticals).
Who are Apollo Hospitals Enterprise's peers?
In the Distribution & pharmacy retail layer of Pharmaceuticals: MedPlus Health Services, Entero Healthcare Solutions, PharmEasy (API Holdings) (not NSE-listed) and Tata 1mg (not NSE-listed).
What is Apollo Hospitals Enterprise's market cap and valuation?
As of 30 Oct 2026: market cap ₹1.21L Cr, P/E 57.8x, ROCE 17.4%, ROE 21.2%, dividend yield 0.24%.